|
Sex (male/female)
|
1.436
|
0.722–2.855
|
0.302
|
–
|
–
|
–
|
|
Age (≤ 55/> 55 years)
|
0.882
|
0.591–1.317
|
0.540
|
–
|
–
|
–
|
|
AST (≤ 40/> 40 U/L)
|
1.316
|
0.854–2.027
|
0.213
|
–
|
–
|
–
|
|
ALT (≤ 40/> 40 U/L)
|
1.018
|
0.674–1.538
|
0.933
|
–
|
–
|
–
|
|
Total bilirubin (< 17.1/≥ 17.1 umol/L)
|
1.032
|
0.649–1.642
|
0.893
|
–
|
–
|
–
|
|
Albumin (> 35/≥ 35 g/L)
|
0.678
|
0.393–1.167
|
0.160
|
–
|
–
|
–
|
|
Tumour size (≤ 5/> 5 cm)
|
2.283
|
1.523–3.422
|
< 0.001
|
1.768
|
1.144–2.732
|
0.010
|
|
Tumour number (solitary/multiple)
|
2.421
|
1.495–3.919
|
< 0.001
|
2.289
|
1.295–4.047
|
0.004
|
|
HBV infection (no/yes)
|
0.904
|
0.438–1.865
|
0.785
|
–
|
–
|
–
|
|
Liver cirrhosis (no/yes)
|
1.095
|
0.694–1.728
|
0.696
|
–
|
–
|
–
|
|
Vascular invasion (no/yes)
|
2.924
|
1.845–4.635
|
< 0.001
|
1.908
|
1.162–3.132
|
0.011
|
|
Differentiation (moderate and well/poor)
|
2.490
|
1.662–3.732
|
< 0.001
|
2.411
|
1.521–3.824
|
< 0.001
|
|
Blood transfusion (no/yes)
|
1.184
|
0.790–1.773
|
0.413
|
–
|
–
|
–
|
|
Hepatic hilar occlusion (no/yes)
|
1.130
|
0.757–1.687
|
0.551
|
–
|
–
|
–
|
|
SII (≤ 330/ > 330)
|
1.382
|
0.911–2.098
|
0.129
|
–
|
–
|
–
|
|
MLR (≤ 0.25/> 0.25)
|
3.801
|
2.341–6.171
|
< 0.001
|
2.037
|
1.154–3.597
|
0.014
|
|
NLR (≤ 2.74/> 2.74)
|
2.513
|
1.599–3.950
|
< 0.001
|
2.070
|
1.212–3.537
|
0.008
|
|
PLR (≤ 88/> 88)
|
1.404
|
0.938–2.100
|
0.099
|
–
|
–
|
–
|
|
SIRI (≤ 1.03/> 1.03)
|
2.248
|
1.496–3.378
|
< 0.001
|
1.320
|
0.773–2.255
|
0.309
|
|
AFP (< 400/≥ 400 ng/mL)
|
1.587
|
1.034–2.437
|
0.035
|
0.914
|
0.557–1.499
|
0.721
|
|
ALBI grade (1/2)
|
1.180
|
0.787–1.768
|
0.423
|
–
|
–
|
–
|
|
BCLC stage (0–A/B–C)
|
2.467
|
1.628–3.740
|
< 0.001
|
1.969
|
1.216–3.187
|
0.006
|
